Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]
<p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Tracey Baird +11 more
core +1 more source
Pan-European early switch/early discharge opportunities exist for hospitalised patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections [PDF]
The objective was to document pan-European real-world treatment patterns and healthcare resource use and estimate opportunities for early switch (ES) from intravenous (IV) to oral antibiotics and early discharge (ED) in hospitalised patients with ...
Solem, C.T. +20 more
core +1 more source
To interpret definition,scope of application,clinical practice and evaluation of adhesive securement device,integrated securement device,subcutaneous anchor securement system,tissue adhesive in "Standards of practice for intravenous therapy"(2021 edition)
TANG Yingying +4 more
doaj
Oral step-down for Staphylococcus aureus bacteraemia: An opportunity for antimicrobial stewardship?
Objectives: Long courses of intravenous antimicrobial therapy are traditionally recommended for the treatment of methicillin sensitive Staphylococcus aureus bacteraemia (MS-SAB), but are not always completed in clinical practice.
Stephen Platts +4 more
doaj +1 more source
The efficacy of midline catheters—a prospective, randomized, active-controlled study
Objectives: This study was performed to investigate whether an intravenous (IV) strategy based on new-generation midline catheters is an efficacious alternative to a conventional IV strategy consisting of peripheral venous catheters and central venous ...
Emma Bundgaard Nielsen +7 more
doaj +1 more source
Intravenous fluid therapy [PDF]
Management ...
openaire +2 more sources
Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice [PDF]
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH).
Emiri Mandeville +44 more
core +2 more sources
BackgroundThe development of numerous demoralization assessment tools has significantly contributed to the field, with the Demoralization Scale being the most frequently utilized.
Yanhua Li +6 more
doaj +1 more source
Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials [PDF]
<p><b>Background and Purpose:</b> A number of factors have been associated with postthrombolysis intracerebral hemorrhage, but these have varied across studies.</p> <p><b>Methods:</b> We examined patients with
Demchuk, A. +8 more
core +1 more source
Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial [PDF]
<p><b>Background and Purpose:</b>Although magnesium is neuroprotective in animal stroke models, no clinical benefit was confirmed in the Intravenous Magnesium Efficacy in Stroke (IMAGES) trial of acute stroke patients.
Alger, J.R. +9 more
core +1 more source

